There are 3164 resources available
1544MO - Clinical trial design and treatment effects: A meta-analysis of randomized-controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications
Presenter: Julia Caroline Michaeli
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Webcast
Invited Discussant 68O and 1172O
Presenter: Bertrand Routy
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Lucia Del Mastro
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
Invited Discussant 1143O and 1144O
Presenter: Talya Dayton
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Christina Ruhlmann
Session: Improving the management of toxicities from immunotherapy
Resources:
Slides
Webcast
Invited Discussant LBA78 and LBA79
Presenter: Tom Wei-Wu Chen
Session: Proffered paper session: Sarcoma
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Christopher Williams
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Webcast
Invited Discussant 1542MO, 1543MO and 1544MO
Presenter: Paolo G. Casali
Session: Mini oral session: Policy and preventive strategies
Resources:
Slides
Webcast
Invited Discussant 1208MO, 1242MO and 1243MO
Presenter: Kersti Oselin
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Slides
Webcast